Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04788147 · ClinicalTrials.gov registry record · NA
Performance and Safety of Biology-Guided Radiotherapy Using the RefleXion Medical Radiotherapy System (BIOGUIDE-X)
A NA study, sponsored by RefleXion Medical.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT04788147 is a NA study that has completed, run by RefleXion Medical. The registered enrollment target is 30 participants.
The verdict
NCT04788147, a NA study, has completed, sponsored by RefleXion Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the performance and safety of Biology-Guided Radiotherapy (BgRT) using the RefleXion Medical Radiotherapy System (RMRS) via optimizing F18-Fluorodeoxyglucose (FDG) dosing, assessing the performance of the Positron Emission Tomography (PET) imaging subsystem for BgRT treatment planning and delivery, including its role as an interlock, and validating the dose delivery performance of the end-to-end BgRT workflow.
Interventions
- DEVICE RMRS IDE Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-03-26 |
| Est. Completion | 2021-12-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04788147
The ClinicalTrials.gov registry entry for NCT04788147 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is RefleXion Medical, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which RMRS IDE Device is the first listed.
NCT04788147 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04788147 about?
NCT04788147 is a clinical study titled "Performance and Safety of Biology-Guided Radiotherapy Using the RefleXion Medical Radiotherapy System (BIOGUIDE-X)". The purpose of this study is to assess the performance and safety of Biology-Guided Radiotherapy (BgRT) using the RefleXion Medical Radiotherapy System (RMRS) via optimizing F18-Fluorodeoxyglucose (FDG) dosing, assessing the performance of the Positron Emission Tomography (PET) imaging subsystem for...
What is the current status of trial NCT04788147?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2021-03-26. Estimated completion is 2021-12-20.
What interventions are being tested in trial NCT04788147?
The interventions under investigation include: RMRS IDE Device (DEVICE).
Who is sponsoring clinical trial NCT04788147?
This trial is sponsored by RefleXion Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.